Evidence map›Paper›PMID 29665788›Full record

ArticleBMC cancer2018

Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.

Xiao-Jie Sun, Ju-Fang Shi, Lan-Wei Guo, Hui-Yao Huang, Neng-Liang Yao, Ji-Yong Gong, Ya-Wen Sun, Guo-Xiang Liu, A-Yan Mao, Xian-Zhen Liao and 23 more

Abstract readHistorical ArticleMulticenter Study
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Xiao-Jie SunSchool of Health Care Management (key Lab of Health Economics and Policy, National Health Commission), Shandong University, Jinan, China.
Ju-Fang ShiOffice of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. shijf@cicams.ac.cn.
Lan-Wei GuoDepartment of Cancer Epidemiology, Henan Office for Cancer Control and Research, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Hui-Yao HuangOffice of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Neng-Liang YaoSchool of Health Care Management (key Lab of Health Economics and Policy, National Health Commission), Shandong University, Jinan, China.
Ji-Yong GongShandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University, Jinan, 250117, China.
Ya-Wen SunShandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University, Jinan, 250117, China.
Guo-Xiang LiuDepartment of Health Economics, School of Health Management, Harbin Medical University, Harbin, China.
A-Yan MaoPublic Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China.
Xian-Zhen LiaoHunan Office for Cancer Control and Research, Hunan Provincial Cancer Hospital, Changsha, China.
Ya-Na BaiInstitute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou, China.
Jian-Song RenOffice of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xin-Yu ZhuOffice of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Jin-Yi ZhouInstitute of Chronic Non-communicable Diseases Prevention and Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Ling MaiDepartment of Institute of Tumor Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Bing-Bing SongHeilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University, Harbin, China.
Yu-Qin LiuCancer Epidemiology Research Center, Gansu Provincial Cancer Hospital, Lanzhou, China.
Lin ZhuTeaching and Research Department, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
Ling-Bin DuZhejiang Office for Cancer Control and Research, Zhejiang Cancer Hospital, Hangzhou, China.
Qi ZhouChongqing Office for Cancer Control and Research, Chongqing Cancer Hospital, Chongqing, China.
Xiao-Jing XingLiaoning Office for Cancer Control and Research, Liaoning Cancer Hospital & Institute, Shenyang, China.
Pei-An LouDepartment of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou, China.
Xiao-Hua SunNingbo Clinical Cancer Prevention Guidance Center, Ningbo NO.2 Hospital, Ningbo, China.
Xiao QiDepartment of Occupational Medicine, Tangshan People's Hospital, Tangshan, China.
Yuanzheng WangDepartment of Economic Operation, Kailuan General Hospital, Tangshan, China.
Rong CaoDepartment of Health Policy and Economic Research, Guangdong Provincial Institute of Public Health, Guangzhou, China.
Ying RenUrban Office of Cancer Early Detection and Treatment, Tieling Central Hospital, Tieling, China.
Li LanInstitute of Chronic disease prevention and control, Harbin Center for Disease Control and Prevention, Harbin, China.
Kai ZhangDepartment of Cancer Prevention, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jie HeDepartment of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jia-Lin WangShandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University, Jinan, 250117, China. wangjialin6681@sina.com.
Min DaiOffice of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
listed authors are on behalf of the Health Economic Evaluation Working Group, Cancer Screening Program in Urban China (CanSPUC)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn China, stomach cancer is the third most common cancer and the third leading cause of cancer death. Few studies have examined Chinese stomach cancer patients' medical expenses and their associated trends. The Cancer Screening Program in Urban China (CanSPUC) is a Major Public Health Project funded by the central government. Through this project, we have extracted patients' medical expenses from hospital billing data to examine the costs of the first course treatments (which refers to 2 months before and 10 months after the date of cancer diagnosis) in Chinese patients with stomach cancer and the associated trends.

methodsThe expense data of 14,692 urban Chinese patients with stomach cancer were collected from 40 hospitals in 13 provinces. We estimated the inflation-adjusted medical expenses per patient during 2002-2011. We described the time trends of medical expenses at the country-level, and those trends by subgroup, and analyzed the compositions of medical expenses. We constructed the Generalized Linear Mixed (GLM) regression model with Poisson distribution to examine the factors that were associated with medical expenses per patient.

resultsThe average medical expenses of the first course treatments were about 43,249 CNY (6851 USD) in 2011, more than twice of that in 2002. The expenses increased by an average annual rate of 7.4%. Longer stay during hospitalization and an increased number of episodes of care are the two main contributors to the expense increase. The upward trend of medical expenses was observed in almost all patient subgroups. Drug expenses accounted for over half of the medical expenses.

conclusionsThe average medical expenses of the first course (2 months before and 10 months after the date of cancer diagnosis) treatments per stomach cancer patient in urban China in 2011 were doubled during the previous 10 years, and about twice as high as the per capita disposable income of urban households in the same year. Such high expenses indicate that it makes economic sense to invest in cancer prevention and control in China.

Indexed as

Health ExpendituresHospitalizationUrban HealthAgedFemaleHistory, 21st CenturyHumansMaleMiddle AgedOdds RatioRetrospective StudiesStomach NeoplasmsChinaHospitalizationMedical expensesStomach cancerUrban

Identifiers

PMID29665788
PMCPMC5905135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.